{
  "thread": {
    "uuid": "e85aeed11250799104f07a2e23a2f104f2889459",
    "url": "https://menafn.com/1109075703/MDMA-Rejection-Raises-New-Questions-On-Psychedelic-Drug-Clinical-Trials",
    "site_full": "menafn.com",
    "site": "menafn.com",
    "site_section": "http://www.menafn.com/rss/menafn_globaltopstories.xml",
    "site_categories": [
      "investing",
      "financial_news",
      "finance"
    ],
    "section_title": "Singapore-Malaysia SEZ Promises A Production Powerhouse",
    "title": "MDMA Rejection Raises New Questions On Psychedelic Drug Clinical Trials",
    "title_full": "MDMA Rejection Raises New Questions On Psychedelic Drug Clinical Trials",
    "published": "2025-01-10T11:09:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://menafn.com/includes/img/logo.jpg",
    "performance_score": 0,
    "domain_rank": 6390,
    "domain_rank_updated": "2025-01-06T23:00:00.000+02:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "e85aeed11250799104f07a2e23a2f104f2889459",
  "url": "https://menafn.com/1109075703/MDMA-Rejection-Raises-New-Questions-On-Psychedelic-Drug-Clinical-Trials",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "MENAFN",
  "published": "2025-01-10T11:09:00.000+02:00",
  "title": "MDMA Rejection Raises New Questions On Psychedelic Drug Clinical Trials",
  "text": "( MENAFN - Investor Brand Network) The U.S. Food and Drug Administration (FDA) recently\nrejected an application\nto approve the use of MDMA as a treatment for post-traumatic stress disorder (PTSD). The MDMA formulation, developed by Lykos Therapeutics, would have been administered in combination with psychotherapy if it had been approved.\nIn its rejection, the federal agency requested for more clinical trials to be done to gather additional data on the drug's effectiveness and...\nRead More>>\nAbout PsychedelicNewsWire\nPsychedelicNewsWire\n(“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within\nthe\nDynamic Brand Portfolio\n@\nIBN\nthat delivers :\n(1) access to a vast network of wire solutions via\nInvestorWire\nto efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;\n(2) article and\neditorial syndication to 5,000+ outlets ;\n(3) enhanced\npress release enhancement\nto ensure maximum impact ;\n(4)\nsocial media distribution\nvia IBN to millions of social media followers ;\nand (5) a full array of tailored\ncorporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.\nTo receive SMS alerts from PsychedelicNewsWire, text“Groovy” to 888-902-4192 (U.S. Mobile Phones Only)\nFor more information, please visit\nPlease see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:\n/Disclaimer\nPsychedelicNewsWire\nSan Francisco, CA\n415.949.5050 Office\n[email protected]\nPsychedelicNewsWire is powered by\nIBN\nMENAFN10012025000224011066ID1109075703",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Health",
    "Science and Technology",
    "Social Issue"
  ],
  "topics": [
    "Health->health treatment and procedure",
    "Health->drug rehabilitation",
    "Science and Technology->scientific research",
    "Science and Technology->medical research",
    "Science and Technology->biomedical science",
    "Social Issue->social services",
    "Social Issue->addiction",
    "Social Issue->social problem"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "rating": null,
  "crawled": "2025-01-10T12:24:44.469+02:00",
  "updated": "2025-01-10T12:24:44.469+02:00"
}